UNSPSC 51332100: Antipsychotic benzamides

Antipsychotic drugs made from benzoic acid amides.

UNSPSC 51332100 Antipsychotic benzamides is a Class code, but the recent state and local opportunities tagged under it diverge significantly from its nominal scope. The three most recent solicitations—a Seminole County, Florida procurement for naloxone and drug deactivation systems, a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescription programs, and a Minnesota Multistate Cooperative Purchasing Alliance RFP for generic multi-source pharmaceuticals and OTC products—span emergency response medications, pharmacy benefit management, and broad-based pharmaceutical supply rather than antipsychotic compounds specifically. The work being solicited reflects state health departments, county public health agencies, and cooperative purchasing alliances buying pharmaceuticals and related systems to support community health, emergency preparedness, and state employee or Medicaid populations, with substantial emphasis on compliance with cGMP, the Drug Supply Chain Security Act, FDA requirements, and established wholesaler networks.

Issuing bodies include state health and human services departments (Texas), county health systems (Seminole County, Florida), and multistate cooperative purchasing vehicles (Minnesota Department of Administration coordinating for multiple states including Oregon). Recent activity concentrates in Florida, Texas, and Minnesota, with the MMCAP cooperative extending reach across participating jurisdictions. Representative solicitations include Seminole County's IFB 60459723LAS for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023; the Texas HHS RFI HHS0017013 on direct-to-manufacturer prescription capabilities, posted April 3, 2026; and MMCAP's RFP S1070000015802 for generic pharmaceuticals and OTC products with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The code shows limited true antipsychotic-specific activity, suggesting that state and local buyers are cataloging broader pharmaceutical procurement under this designation or that antipsychotic benzamides represent a small fraction of actual pharmaceutical acquisitions.